Phenazepam
SIGMA/SML0647 - ≥97% (HPLC)
Synonym: 7-
CAS Number: 51753-57-2
Empirical Formula (Hill Notation): C15H10BrClN2O
Molecular Weight: 349.61
Linear Formula: C15H10BrClN2O
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to beige |
| drug control | Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet |
| form | powder |
| InChI | 1S/C15H10BrClN2O/c16-9-5- |
| InChI key | CGMJQQJSWIRRRL-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Brc1cc2c(cc1)NC(=O)CN=C2c |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Phenazepam is an agonist of the γ-Aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex. |
| Biochem/physiol Actions: | Phenazepam is the benzodiazepine that exhibit anticonvulsive, anxiolytic, sedative and hypnotic effects in humans and experimental animals. Phenazepam is an agonist of the γ-Aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex. |
| Features and Benefits: | This compound is featured on the GABAA Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H319 - H340 - H360 - H362 |
| Precautionary statements | P201 - P260 - P263 - P305 + P351 + P338 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 46-60-61-36-64 |
| Safety Statements | 53-26-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |



